Loading…
Tuesday, April 30 • 13:45 - 14:25
PANEL: The HCP Experience Beyond 2024: What does Pharma Need to know?

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.
  • What we mean by “the HCP experience”? When considering the HCP Experience, what has changed post COVID? How has the physician/patient interaction changed?
  • How does HCP Experience relate to your product/market/therapy/patient populations?
  • Where do data/analytics and technology play a role when considering the HCP Experience?
  • Which digital (all) channels should HCP-driven brands be focusing on for their own digital strategies in a post-pandemic world?
  • How real-time is data/analytics access for the field allowing for immediate personalization?  
  • How will the Pharma “rep” of the future look different?
  • What different concepts of “value” should pharma be providing HCPs in 2025+?


Speakers
avatar for Damon Basch

Damon Basch

VP, Strategic Partnerships, Veradigm
avatar for Maureen Shannon

Maureen Shannon

Head Biologics Marketing, Sun Pharma
avatar for Tarak Shah

Tarak Shah

Senior Director, Head of US Customer Engagement, Ferring Pharmaceuticals
avatar for Jey Bryant

Jey Bryant

Marketing Director, Sumitomo Pharma America, Inc.
avatar for Amy Musolino

Amy Musolino

Fmr Chief Marketing Officer Pharmaceutical Diagnostics Americas, GE Healthcare


Tuesday April 30, 2024 13:45 - 14:25 EDT

Attendees (3)